← Open Payments lookup

PAMELA JACKSON: Open Payments

NPI 1699851931 · OPELOUSAS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$501 in 18 payments from 11 companies in 2025. Trend: 2023 $901 · 2024 $329 · 2025 $501

Food & beverage: $501
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc1$121
Neurocrine BioSciences, Inc.4$105
Teva Pharmaceuticals USA, Inc.3$60
Otsuka America Pharmaceutical, Inc.2$50
Vanda Pharmaceuticals Inc.2$39
ABBVIE INC.1$29
Alkermes, Inc.1$24
E.R. Squibb & Sons, L.L.C.1$21
Indivior Inc.1$20
Luye Pharma (USA) Ltd.1$17

Products named: INVEGA SUSTENNA, INGREZZA, REXULTI, UZEDY, FANAPT, VRAYLAR, ARISTADA, COBENFY.

Industry payments across LA — which companies pay providers there.